Clinical significance of giant negative T waves in hypertrophic cardiomyopathy

Department of Cardiological Sciences, St. George's Hospital Medical School, London, England.

To assess the clinical significance of "giant" negative T waves in patients with hypertrophic cardiomyopathy from Western nations, clinical, echocardiographic, radionuclide and 48 h electrocardiographic (ECG) monitoring findings were compared in 27 patients with and 56 patients without giant negative T waves. Patients with giant negative T waves were older at diagnosis (43 +/- 15 versus 32 +/- 14 years, p less than 0.005), had greater ECG voltage (SV1 + RV5 = 57 +/- 20 versus 37 +/- 18 mm, p less than 0.001) and had a more vertical frontal plane axis (38.4 +/- 34 versus 13.4 +/- 45 degrees, p less than 0.05). Left ventricular wall thickness on two-dimensional echocardiography was similar at the mitral valve level (mean 16.5 +/- 4 versus 16.6 +/- 3 cm), but was greater at the papillary muscle level (mean 20.7 +/- 5 versus 17.6 +/- 3 mm, p less than 0.01) and apex (mean 23.3 +/- 5 versus 17.3 +/- 3 mm, p less than 0.001) in patients with giant negative T waves. Fewer patients with giant negative T waves had asymmetric septal hypertrophy (12 [44%] of 27 versus 36 [64%] of 56, p = 0.08) or systolic anterior motion of the mitral valve (4 [14%] of 27 versus 25 [45%] of 56, p less than 0.01), whereas left ventricular end-diastolic (44.1 +/- 6 versus 39.6 +/- 5 mm, p = 0.01) and end-systolic dimensions (27.8 +/- 4 versus 24 +/- 6 mm, p less than 0.05) were greater in this group. Nonsustained ventricular tachycardia was seen on ECG monitoring in 21% of patients in both groups.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C. A. Dumont, L. Monserrat, R. Soler, E. Rodriguez, X. Fernandez, J. Peteiro, A. Bouzas, B. Bouzas, and A. Castro-Beiras Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance Eur. Heart J., July 2, 2006; 27(14): 1725 - 1731. [Abstract] [Full Text] [PDF]

				M. J. Eriksson, B. Sonnenberg, A. Woo, P. Rakowski, T. G. Parker, E. D. Wigle, and H. Rakowski Long-term outcome in patients with apical hypertrophic cardiomyopathy J. Am. Coll. Cardiol., February 20, 2002; 39(4): 638 - 645. [Abstract] [Full Text] [PDF]

				M. Abe, M. Hamada, H. Matsuoka, Y. Shigematsu, T. Sumimoto, H. Okayama, H. Kawakami, S. Nakata, and K. Hiwada Relation Between Postpacing T Wave Changes and Myocardial Scintigraphic Characteristics in Patients with Ventricular Demand Pacemaker Angiology, June 1, 1995; 46(6): 489 - 495. [Abstract] [PDF]

				B. J. Maron, A. Pelliccia, and P. Spirito Cardiac Disease in Young Trained Athletes : Insights Into Methods for Distinguishing Athlete's Heart From Structural Heart Disease, With Particular Emphasis on Hypertrophic Cardiomyopathy Circulation, March 1, 1995; 91(5): 1596 - 1601. [Full Text]